Life Sciences Group Of The Year: Covington & Burling

Law360, New York (January 9, 2014, 4:01 PM EST) -- Covington & Burling LLP delivered for drugmakers on three continents in 2013, spearheading a momentous investment by U.K.-based AstraZeneca PLC, notching numerous litigation triumphs on U.S. soil and helping streamline product approvals in China, placing it among Law360's Life Sciences Practice Groups of the Year.

The firm secured its repeat appearance in part through representation of AstraZeneca in the pharmaceutical giant’s $420 million wager on Massachusetts startup Moderna Therapeutics Inc., which has been pursuing pioneering medicines that use messenger RNA to provoke cellular responses.

AstraZeneca is...
To view the full article, register now.